The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography.
暂无分享,去创建一个
[1] S. Pedersen,et al. Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. , 2012, The American journal of cardiology.
[2] H. Parving,et al. Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria , 2011, Cardiovascular diabetology.
[3] Yujie Zhou,et al. Plasma Osteoprotegerin Levels and Long‐Term Prognosis in Patients With Intermediate Coronary Artery Lesions , 2011, Clinical cardiology.
[4] J. Hansen,et al. Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study , 2011, Journal of thrombosis and haemostasis : JTH.
[5] C. Mélot,et al. Osteoprotegerin and progression of coronary and aortic calcifications in chronic kidney disease. , 2010, Transplantation proceedings.
[6] J. Igland,et al. Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris. , 2010, Atherosclerosis.
[7] P. Grzelak,et al. Serum Osteoprotegerin Is a Predictor of Progression of Atherosclerosis and Coronary Calcification in Hemodialysis Patients , 2010, Nephron Clinical Practice.
[8] Avijit Lahiri,et al. Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. , 2010, Journal of the American College of Cardiology.
[9] Yun Zhang,et al. Increased plasma osteoprotegerin levels are associated with the presence and severity of acute coronary syndrome , 2008, Acta cardiologica.
[10] J. Herlitz,et al. Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes. , 2008, Journal of the American College of Cardiology.
[11] A. Lahiri,et al. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. , 2006, Journal of the American College of Cardiology.
[12] G. Hansson,et al. Enhanced T-Cell Expression of RANK Ligand in Acute Coronary Syndrome: Possible Role in Plaque Destabilization , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[13] A. Avignon,et al. Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients. , 2005, Diabetes care.
[14] K. Sung,et al. Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein. , 2005, Clinical science.
[15] A. Ruello,et al. Osteoprotegerin, IL-6, IL-1, TNF-alpha and TGF-beta concentrations during acetate-free biofiltration. , 2005, Journal of nephrology.
[16] L. Hofbauer,et al. Increased osteoprotegerin serum levels in men with coronary artery disease. , 2003, The Journal of clinical endocrinology and metabolism.
[17] Y. Ikari,et al. Serum Osteoprotegerin Levels Are Associated With the Presence and Severity of Coronary Artery Disease , 2002, Circulation.
[18] G. Gensini,et al. A more meaningful scoring system for determining the severity of coronary heart disease. , 1983, The American journal of cardiology.
[19] P. Nestel,et al. Severity of coronary atherosclerosis related to lipoprotein concentration. , 1978, British medical journal.
[20] A. Wykrętowicz,et al. The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density. , 2011, Kardiologia polska.